Cargando…
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival
BACKGROUND: This study was conducted to determine if anti-tumor vaccination administered prior to partial debulking surgery could improve survival using a murine solid tumour model. METHODS: Tumor incidence and survival rates were compared in mice bearing subcutaneous AB1-HA mesothelioma tumors that...
Autores principales: | Fisher, Scott A, Cleaver, Amanda, Lakhiani, Devina D, Khong, Andrea, Connor, Theresa, Wylie, Ben, Lesterhuis, W Joost, Robinson, Bruce WS, Lake, Richard A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156969/ https://www.ncbi.nlm.nih.gov/pubmed/25186961 http://dx.doi.org/10.1186/s12967-014-0245-7 |
Ejemplares similares
-
The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40
por: Khong, Andrea, et al.
Publicado: (2014) -
Transient Treg depletion enhances therapeutic anti‐cancer vaccination
por: Fisher, Scott A., et al.
Publicado: (2016) -
Restoration of defective cross-presentation in tumors by gemcitabine
por: McDonnell, Alison M, et al.
Publicado: (2015) -
Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation
por: McDonnell, Alison M., et al.
Publicado: (2012) -
Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity
por: Lesterhuis, W. Joost, et al.
Publicado: (2013)